HIV-1 rebound after HAART discontinuation examined

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1249, 2000-01, pp. : 18-18

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cognitive impairment associated with HIV-1 infection seems to be improved by HAART

By  

Inpharma, Vol. 1, Iss. 1277, 2001-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite

Efavirenz: shifting the HAART paradigm in adult HIV-1 infection

By Moyle G.J.  

Expert Opinion on Investigational Drugs, Vol. 8, Iss. 4, 1999-04 ,pp. : 473-486

Informa Healthcare

Access to resources Recommend Favorite

Antiretroviral Compounds: Mechanisms Underlying Failure of HAART to Eradicate HIV-1

By  

Current Medicinal Chemistry, Vol. 12, Iss. 15, 2005-07 ,pp. : 1705-1719

Bentham Science Publishers

Access to resources Recommend Favorite

Viral Reservoirs an Impediment to HAART: New Strategies to Eliminate HIV-1

By  

Current Drug Targets - Infectious Disorders, Vol. 3, Iss. 2, 2003-01 ,pp. : 179-206

Bentham Science Publishers

Access to resources Recommend Favorite

HAART to HAART: Current and Future Pharmacotherapies For HIV

By Adis International Limited  

Pharmaceutical & Diagnostic Innovation, Vol. 2, Iss. 6, 2004-11 ,pp. : 17-21

Adis International

Access to resources Recommend Favorite